CARA is here on a 15 minute chart. The earnings report is due March 4th. The price action is already demonstrative of bullish momentum. CARA rose 60% this past week. It is still on sale at 95% off its all time high. Spiking buying volume, and so an upgoing Price Vulme Trend and squeeze release triggers on lower time frames all have CARA moving well prior to...
Cara Therapeutics (NASDAQ: NASDAQ:CARA ) is undergoing a significant transformation as it announces strategic shifts in its operations, including substantial layoffs and a departure at the executive level. The biopharmaceutical company is redirecting its focus towards its late-stage notalgia paresthetica program, necessitating a withdrawal from advanced chronic...
On the 4hr and 8 hr there are low signals puddling up all over the place. This is ready to pop. In the Past the lowest pop witht hese same signals was 61% move. Taking this to at the lowest $16.85 by iCantw84it 03.26/22
$CARA Target 17.68 for 24.42% Or double position at 10.74 I'm not sure if I published this one when I first bought on that hellacious dip, haha. 🤣 Anyway, it looks like it found a little bit of support here so, might as well publish it here This might not be a trade you want to play... I will post better ones... just for reference here. — On the far right of...
$CARA WATCHING 23.88 for Entry
As you can see we are sitting in the mid range of the support and resistance . You can clearly see a pattern in movement between spikes. We have 3 levels to enter here. We can either jump on the red line which is a pretty aggressive entry, or we can find a entry on the support level / red level, which is more safe but there is also a chance to miss the entry....
Very nice symmetry in this H&S pattern. I expect an explosive move
An analysis for Cara a rectangle has formed currently sitting at middle point of rectangle. I would short this. Interesting price action I might do some more development on CARA
Looking for a rejection at 0.25 line for cara. Movement down on the S&P index due to a bearish divergence
Light weight company with a strong cannabis product niche. Technical bullflag setup, needs macro bull trend to hold up, and then a company specific catalyst to breakout for new ATHs
Initial spike in volume was caused by fast track and phase 3 news. Nothing to drive the price at the moment. My best best is that we'll see CARA retest $19.65 within a week or so.
don't have to be Andrew Yang to do the MATH on this one
Cara Therapeutics is back on the strong resistance line that has been tested 4 times. Only once, in June 2017, was this briefly broken after FDA breakthrough therapy designation. CR845 reduces itching in patients with chronic liver insufficiency. This brought in June 2018 3 large pharmaceutical companies on the plan, who wanted to market this product against once...
I think we may have topped out for now. If you are not in a bullish position right now, perhaps it is wise to hold until resistance is broken, or wait for it to retrace to the 50MA. Indicators show that we're a tiny tad extended atm. Take a look at ZYNE, if CBD Pharma is your game. Just my 2 cents. It's free. Trade with caution.